When rumors emerged nearly a year ago that Bayer might be planning to exit the animal-health business, Eli Lilly spinoff Elanco was not at the top of any market-watcher’s list of potential buyers—especially not after it became clear that several private equity players were interested in the asset. Turns out Elanco was interested, and the… Read More »
Fitness trackers like the Apple Watch now allow you to detect heart conditions such as atrial fibrillation. That’s not always a good thing, says doctor Margaret McCartney Technology | Comment 17 July 2019 Josie Ford By Margaret McCartney SELF-EMPOWERED, self-motivated, self-aware: we have got used to the idea that more knowledge about our health is… Read More »
Valeant, now Bausch Health, paid $ 1 billon in 2015 for Sprout Pharmaceuticals’ female libido drug Addyi, only to sell it back in 2017. Now as the drug is still nowhere near the blockbuster status Valeant once touted, a rival has arrived. The FDA late Friday approved AMAG Pharmaceuticals’ Vyleesi (bremelanotide) to treat premenopausal women with… Read More »
Six years after federal prosecutors first targeted Novartis for an alleged kickback scheme involving $ 10,000 dinners and fishing trips for doctors, signs pointed to the Swiss drugmaker finally having its day in court. Now, it looks like that may not happen. Novartis could be approaching a billion-dollar settlement with the U.S. government as part… Read More »